ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 204

Histone Methylation Profiling in Peripheral White Blood Cells As a Candidate Biomarker for Behcet’s Disease

Yoshimi Aizaki1,2, Yasuto Araki1,2, Kojiro Sato1, Yuji Akiyama1 and Toshihide Mimura1,2, 1Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan, 2Project Research Division, Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Behcet's syndrome, Histone Modification and epigenetics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Innate Immunity and Rheumatic Disease Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Behcet’s disease (BD) is a chronic recurrent, multisystem inflammatory disorder. The phenotypic characteristics include oral aphtha, genital ulcers, uveitis and skin lesions. No specific laboratory tests have been known in BD. Reported in BD have been an increased number of γδ T cells in the peripheral blood and hyperactivity of neutrophils. Although a line of evidence has suggested genetic contributions to the disease, etiopathogenesis of BD is still unclear and non-genetic factors, like environment, infection or epigenetics may play pivotal roles in the pathogenesis.  Epigenetic mechanisms including posttranslational histone modifications are known to regulate gene expression without altering the genomic sequence. The association of specific histone modifications with gene expression is very well defined, such as tri-methylation of histone 3 lysine 27 (H3K4me27), which may be characteristic of repressed genes, or tri-methylation of histone 3 lysine 4 (H3K4me3), which may present in many active genes. Histone modifications in major rheumatic diseases, such as rheumatoid arthritis, have been investigated, while studies on histone modifications in BD are limited. From the functional point of view, it is important to analyze differences of histone modifications in each functional subclass of the entire peripheral blood nucleated cells. To examine the histone modifications of peripheral blood mononuclear cells (PBMCs) and neutrophils in BD, we have established a novel method analyzing histone methylation in each subset by fluorescence-activated cell sorting (FACS).

Methods: PBMCs and neutrophils were obtained from 13 patients with BD and 12 healthy controls (HC). Diagnosis of BD was made according to the criteria of Behcet’s Disease Research Committee of Japan, Ministry of Health, Labour and Welfare of Japan. Four immune cell types were stained surface epitopes: CD4+ T cells, CD8+ T cells, γδ T cells, and CD16+CD66b+ neutrophils. Flow cytometry for H3K4me3 and H3K4me27 were normalized using isotype controls. All samples were analyzed on a FACSCalibur cytometer. As a quantitative measure of H3K4me3 and H3K27me3, mean fluorescence intensity (MFI) was used.

Results:   H3K27me3 and H3K4me3 were detected in CD4+ T cells, CD8+ T cells, γδ T cells, and CD16+CD66b+ neutrophils. H3K27me3 MFI levels were not significantly different in those four immune cell types in BD and HC. In contrast, H3K4me3 MFI levels of BD in γδ T cells were significantly increased compared with HC. H3K4me3/H3K27me3 MFI ratio was significantly lower in neutrophils of BD and higher in γδ T cells of BD than that of HC. H3K4me3 MFI and H3K4me3/H3K27me3 MFI ratio of active BD were significantly increased in γδ T cells as compared to inactive BD.

Conclusion:   Difference in histone modifications could be detected by FACS in peripheral white blood cells in BD patients. Aberrant histone methylation may be associated with the pathogenesis of BD. It is suggested that histone methylation could be a new candidate-biomarker for BD.


Disclosure: Y. Aizaki, None; Y. Araki, None; K. Sato, None; Y. Akiyama, None; T. Mimura, None.

To cite this abstract in AMA style:

Aizaki Y, Araki Y, Sato K, Akiyama Y, Mimura T. Histone Methylation Profiling in Peripheral White Blood Cells As a Candidate Biomarker for Behcet’s Disease [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/histone-methylation-profiling-in-peripheral-white-blood-cells-as-a-candidate-biomarker-for-behcets-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/histone-methylation-profiling-in-peripheral-white-blood-cells-as-a-candidate-biomarker-for-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology